Wordt geladen...
Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status
This study was designed to retrospectively evaluate the efficacy and safety of modified FOLFOX-6 regimen in advanced gastric cancer (AGC) patients with poor performance status (PS). From January 2005 to August 2010, 23 AGC patients with poor PS who received mFOLFOX-6 as first-line chemotherapy were...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3362383/ https://ncbi.nlm.nih.gov/pubmed/22740925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.496 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|